DESCRIPTION:
The proprietary product is 98% natural and has major indications for acne, psoriasis, dermatitis, podiatry, and osteoarthritis.

KEY ASPECTS:

FDA approved as OTC under Anti-itch Monograph
Owns 2 patents with 2 pending
Exclusive international distribution rights
Current testing by Moffitt Cancer Institute and Morton Plant Mease Hospital
No pain or scaring
Debt-free
No venture capitalist funding has been accepted in the past
Portion of product concentrate can be used for 13 other consumer product applications
All ingredients on the FDA G.R.A.S.E list
Offers an alternative to outpatient surgery
Anti-viral, anti-bacterial and anti-fungal properties
Affordable
Sizes available are 1oz. samples and 4oz. bottles

OPPORTUNITIES:

Promote Osteoarthritis medication (patent pending)
Pipeline of other patents applied for
Develop an aggressive sales force
Excellent revenue source for dermatologists, pediatricians, dental surgeons, podiatrists, non-chain pharmacies, walk-in clinics, skilled nursing facilities, and veterinarians

INTERESTED IN THIS OPPORTUNITY?
Click the contact button to the left, call 813-898-2350, or email pmanry@benchmarkintl.com and include the client code BN000028640.

Benchmark International

Benchmarks Exclusive Opportunities

Ala-Septic is a Patented, Topical OTC Medication – BN000028640

Ala-Septic is a Patented, Topical OTC Medication – BN000028640

Login